Dr. Brian Masao Inouye, MD

Dr. Inouye practices at Albany Medical Center / South Clinical Campus in Albany, New York.

Dr. Inouye's NPI, 1467871178, was assigned on April 9, 2014. Dr. Inouye holds New York license 310602.

Dr. Inouye's primary practice is Albany Medical Center / South Clinical Campus, at 25 Hackett Blvd, Albany, NY 12208 in Albany County. The practice phone is (866) 262-7476.

Dr. Inouye's primary practice is Albany Medical Center / South Clinical Campus in Albany, New York. Dr. Inouye is also affiliated with Albany Medical Center. The medical group on file is Albany Med EmUrgentCare. Dmand AI also links Dr. Inouye to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inouye practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Inouye's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Inouye's licenses on file in 2 states: New York and North Carolina.

CMS data shows 611 Medicare services from Dr. Inouye across 13 procedure codes in 2024, for 242 Medicare patients. Medicare paid $39,398 for them.

CMS counts 242 Medicare patients who saw Dr. Inouye in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Inouye's median patient age at 62, with 15% women.

In 2024, Dr. Inouye wrote 435 Medicare Part D claims for 120 patients. 77% of them were for generic drugs. CMS names the drug for 356 of them, across 11 drugs with 11 or more claims each, at $91,671 in total drug cost. In 2023, CMS named 299 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Inouye for performance year 2024, reported through an alternative payment model (APM). Dr. Inouye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Inouye as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Inouye in 2025. 2025 was the busiest year, with 3. Dr. Inouye's most frequent co-authors are Michael Thadeus Mario Pignanelli, MD, Rauf Shahbazov, MD and Rebecca Jayne Stetzer, MD.

CMS Open Payments shows 64 general payments to Dr. Inouye from 14 drug and device companies from 2020 to 2025. Grants make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $53,458.